Corona Remedies Commences EU-GMP Approved Hormone Facility Production

Corona Remedies Ltd has announced the commencement of commercial production at its new EU-GMP approved Women's Hormone manufacturing facility located in Bhayla, Ahmedabad. This state-of-the-art facility, inaugurated by Chairman Dr. K. L. Mehta and long-serving women employees, is designed to meet the growing global demand for specialized hormone therapies. The facility boasts advanced manufacturing technologies, including closed-loop systems and precision environmental controls, with an annual capacity of 194 million tablets/capsules and 1.5 million ointments/gels. This expansion is expected to increase the company's in-house hormone manufacturing capacity by nearly 20%, reinforcing its commitment to women's healthcare and strengthening India's pharmaceutical manufacturing capabilities for both domestic and international markets.